| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry; mouse; 1:500; loading ...; fig s11b
| Naito M, Mori M, Inagawa M, Miyata K, Hashimoto N, Tanaka S, et al. Dnmt3a Regulates Proliferation of Muscle Satellite Cells via p57Kip2. PLoS Genet. 2016;12:e1006167 pubmed publisher |
- western blot; human; 1:1000; fig s11e
| Shao Z, Zhang R, Khodadadi Jamayran A, Chen B, Crowley M, Festok M, et al. The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis. Nat Commun. 2016;7:10869 pubmed publisher |
| Howlin J, Cirenajwis H, Lettiero B, Staaf J, Lauss M, Saal L, et al. Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours. Peerj. 2015;3:e788 pubmed publisher |
- immunocytochemistry; human; fig s9e
- western blot; human; fig s9d
| Wang P, Alvarez Perez J, Felsenfeld D, Liu H, Sivendran S, Bender A, et al. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med. 2015;21:383-8 pubmed publisher |
| Shelby S, Veatch S, Holowka D, Baird B. Functional nanoscale coupling of Lyn kinase with IgE-Fc?RI is restricted by the actin cytoskeleton in early antigen-stimulated signaling. Mol Biol Cell. 2016;27:3645-3658 pubmed |
| Maggi E, Trillo Tinoco J, Struckhoff A, Vijayaraghavan J, del Valle L, Crabtree J. Retinoblastoma-binding protein 2 (RBP2) is frequently expressed in neuroendocrine tumors and promotes the neoplastic phenotype. Oncogenesis. 2016;5:e257 pubmed publisher |
| Moreno Lorenzana D, Avilés Vazquez S, Sandoval Esquivel M, Alvarado Moreno A, Ortiz Navarrete V, Torres MartÃnez H, et al. CDKIs p18(INK4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI. Cell Cycle. 2016;15:1276-87 pubmed publisher |
| Syu J, Chi J, Kung H. Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia. Oncotarget. 2016;7:14659-72 pubmed publisher |
| Aiken C, Tarry Adkins J, Penfold N, Dearden L, Ozanne S. Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid peroxidation in female mouse offspring exposed to an obesogenic maternal diet. FASEB J. 2016;30:1548-56 pubmed publisher |
| Sánchez A, Calpena A, Clares B. Evaluating the Oxidative Stress in Inflammation: Role of Melatonin. Int J Mol Sci. 2015;16:16981-7004 pubmed publisher |
| Gęgotek A, Skrzydlewska E. The role of transcription factor Nrf2 in skin cells metabolism. Arch Dermatol Res. 2015;307:385-96 pubmed publisher |
| Liu W, Xu C, Wan H, Liu C, Wen C, Lu H, et al. MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells. Int J Mol Med. 2014;34:420-8 pubmed publisher |
| Panngom K, Lee S, Park D, Sim G, Kim Y, Uhm H, et al. Non-thermal plasma treatment diminishes fungal viability and up-regulates resistance genes in a plant host. PLoS ONE. 2014;9:e99300 pubmed publisher |
| Hamajima N, Johmura Y, Suzuki S, Nakanishi M, Saitoh S. Increased protein stability of CDKN1C causes a gain-of-function phenotype in patients with IMAGe syndrome. PLoS ONE. 2013;8:e75137 pubmed publisher |
| Rong M, Chen G, Dang Y. Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro. BMC Cancer. 2013;13:21 pubmed publisher |
| Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G, et al. MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway. Mol Biol Cell. 2013;24:42-55 pubmed publisher |
| Hayley M, Bourbigot S, Booth V. Self-association of an activating natural killer cell receptor, KIR2DS1. PLoS ONE. 2011;6:e23052 pubmed publisher |
| Patel L, Sun W, Glasson S, Morris E, Flannery C, Chockalingam P. Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet Disord. 2011;12:164 pubmed publisher |
| Negrotto S, Hu Z, Alcazar O, Ng K, Triozzi P, Lindner D, et al. Noncytotoxic differentiation treatment of renal cell cancer. Cancer Res. 2011;71:1431-41 pubmed publisher |
| Farkas B, Boldizsar F, Tarjanyi O, Laszlo A, Lin S, Hutas G, et al. BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance. Arthritis Res Ther. 2009;11:R21 pubmed publisher |
